These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19958580)

  • 61. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.
    Labiris NR; Dolovich MB
    Br J Clin Pharmacol; 2003 Dec; 56(6):600-12. PubMed ID: 14616419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does electrostatic charge affect powder aerosolisation?
    Adi H; Kwok PC; Crapper J; Young PM; Traini D; Chan HK
    J Pharm Sci; 2010 May; 99(5):2455-61. PubMed ID: 19941330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhalation therapy: alternative systems--an overview.
    Knecht A
    J Aerosol Med; 1991; 4(3):189-92. PubMed ID: 10147678
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
    Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
    Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bioengineering of therapeutic aerosols.
    Edwards DA; Dunbar C
    Annu Rev Biomed Eng; 2002; 4():93-107. PubMed ID: 12117752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.
    Bohr A; Beck-Broichsitter M
    Ther Deliv; 2015; 6(5):621-36. PubMed ID: 26001177
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation.
    Pornputtapitak W; El-Gendy N; Mermis J; O'Brien-Ladner A; Berkland C
    Int J Pharm; 2014 Feb; 462(1-2):19-28. PubMed ID: 24374223
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Chew NY; Chan HK
    J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regional aerosol deposition in the human airways: The SimInhale benchmark case and a critical assessment of in silico methods.
    Koullapis P; Kassinos SC; Muela J; Perez-Segarra C; Rigola J; Lehmkuhl O; Cui Y; Sommerfeld M; Elcner J; Jicha M; Saveljic I; Filipovic N; Lizal F; Nicolaou L
    Eur J Pharm Sci; 2018 Feb; 113():77-94. PubMed ID: 28890203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transport of ellipsoid fibers in oscillatory shear flows: Implications for aerosol deposition in deep airways.
    Shachar-Berman L; Ostrovski Y; De Rosis A; Kassinos S; Sznitman J
    Eur J Pharm Sci; 2018 Feb; 113():145-151. PubMed ID: 28942008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers.
    Buttini F; Rozou S; Rossi A; Zoumpliou V; Rekkas DM
    Eur J Pharm Sci; 2018 Feb; 113():64-76. PubMed ID: 29104067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 100 Years of Drug Delivery to the Lungs.
    Lavorini F; Buttini F; Usmani OS
    Handb Exp Pharmacol; 2019; 260():143-159. PubMed ID: 31792683
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of particle morphology on the triboelectrification in dry powder inhalers.
    Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
    Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways.
    Duvivier DH; Chiap P; Crommen J; Lekeux P
    Vet Res; 1997; 28(6):557-64. PubMed ID: 9428149
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols.
    Kwok PC; Chan HK
    Pharm Res; 2008 Feb; 25(2):277-88. PubMed ID: 17619997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paediatric pulmonary drug delivery: considerations in asthma treatment.
    Berger WE
    Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emerging inhalation aerosol devices and strategies: where are we headed?
    Zhou QT; Tang P; Leung SS; Chan JG; Chan HK
    Adv Drug Deliv Rev; 2014 Aug; 75():3-17. PubMed ID: 24732364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of budesonide nanocluster dry powder aerosols: preformulation.
    El-Gendy N; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3434-44. PubMed ID: 22623018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.